PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
PROGRESS
The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement
1 other identifier
interventional
2,250
6 countries
80
Brief Summary
This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
80 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2021
CompletedFirst Posted
Study publicly available on registry
May 17, 2021
CompletedStudy Start
First participant enrolled
October 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2037
December 17, 2025
October 1, 2025
7.6 years
May 12, 2021
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Primary Effectiveness Endpoint
Non-hierarchical composite of death, and heart failure hospitalization or event
2 years
Primary Safety Endpoint
Non-hierarchical composite of death, stroke, life threatening or fatal bleeding, acute kidney injury stage 4, hospitalization due to device- or procedure-related complication, and valve dysfunction requiring reintervention
30 days
Secondary Outcomes (5)
Death, stroke, or heart failure hospitalization
2 years
Alive and Kansas City Cardiomyopathy Questionnaire (KCCQ) score improvement ≥10 points from baseline sustained through 2 years
2 years
Heart failure hospitalization
2 years
Left ventricle (LV) mass index
2 years
Diastolic dysfunction ≥ Grade 2
2 years
Study Arms (2)
TAVR
EXPERIMENTALTranscatheter Aortic Valve Replacement (TAVR)
CS
NO INTERVENTIONClinical Surveillance (CS)
Interventions
Patients will be implanted with a SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA heart valve
Eligibility Criteria
You may qualify if:
- years of age or older at time of randomization
- Moderate aortic stenosis
- Subject has symptoms or evidence of cardiac damage/dysfunction
- The subject or subject's legal representative has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent.
You may not qualify if:
- Native aortic annulus size unsuitable for the THV
- Anatomical characteristics that would preclude safe transfemoral placement of the introducer sheath or safe passage of the delivery system
- Aortic valve is unicuspid or non-calcified
- Bicuspid aortic valve with an aneurysmal ascending aorta \> 4.5 cm or severe raphe/leaflet calcification
- Pre-existing mechanical or bioprosthetic aortic valve
- Severe aortic regurgitation
- Prior balloon aortic valvuloplasty to treat severe AS
- LVEF \< 20%
- Left ventricular outflow tract calcification that would increase the risk of annular rupture or significant paravalvular leak post-TAVR
- Cardiac imaging evidence of intracardiac mass, thrombus, or vegetation
- Coronary or aortic valve anatomy that increases the risk of coronary artery obstruction post-TAVR
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (80)
Heart Center LLC, Huntsville
Huntsville, Alabama, 35801, United States
Tucson Medical Center
Tucson, Arizona, 85712, United States
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Huntington Hospital
Pasadena, California, 91105, United States
Eisenhower Desert Cardiology Center
Rancho Mirage, California, 92270, United States
Bay Area Structural Heart at Sutter Health
San Francisco, California, 94109, United States
Kaiser San Francisco Medical Center
San Francisco, California, 94118, United States
University of California San Francisco
San Francisco, California, 94143, United States
Santa Barbara Cottage Hospital
Santa Barbara, California, 93105, United States
Stanford Univeristy
Stanford, California, 94305, United States
UC Health Medical Center of the Rockies
Loveland, Colorado, 80538, United States
Yale Universtiy
New Haven, Connecticut, 06510, United States
The Cardiac & Vascular Institute Research Foundation
Gainesville, Florida, 32605, United States
Baptist Health Research Center
Jacksonville, Florida, 32207, United States
Sarasota Memorial Health Care System
Sarasota, Florida, 34239, United States
Emory University Atlanta
Atlanta, Georgia, 30308, United States
Piedmont Heart Institute
Atlanta, Georgia, 30309, United States
Saint Alphonsus
Boise, Idaho, 83704, United States
Rush University Medical Center
Chicago, Illinois, 60612, United States
Alexian Brothers Hospital
Lisle, Illinois, 60532, United States
Ascension Via Christi St. Francis
Wichita, Kansas, 67226, United States
Louisiana State University
New Orleans, Louisiana, 70112, United States
Ochsner Clinical Foundation
New Orleans, Louisiana, 70121, United States
Massachusetts General Hospital Boston
Boston, Massachusetts, 02114, United States
Minneapolis Heart Institue, St. Paul's
Minneapolis, Minnesota, 55102, United States
CentraCare Heart and Vascular Center
Saint Cloud, Minnesota, 56303, United States
Saint Luke's Hospital of Kansas City Mid America
Kansas City, Missouri, 64111, United States
St. Patrick Hospital
Missoula, Montana, 59802, United States
Mary Hitchcock Memorial Hospital
Lebanon, New Hampshire, 03756, United States
Atlantic Health System Hospital Corp - Morristown Medical Center
Morristown, New Jersey, 07960, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
The Valley Hospital
Ridgewood, New Jersey, 07450, United States
University of Buffalo Kaleida Health
Buffalo, New York, 14203, United States
NYU Langone Hospital - Long Island
Mineola, New York, 11501, United States
NYU Langone Health
New York, New York, 10016, United States
Columbia University Irving Medical Center/NYPH
New York, New York, 10032, United States
Rochester General Hospital
Rochester, New York, 14621, United States
St. Francis Hospital
Roslyn, New York, 11576, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
Moses Cone Memorial Hospital
Greensboro, North Carolina, 27401, United States
The Christ Hospital
Cincinnati, Ohio, 45219, United States
Mount Carmel Health System
Columbus, Ohio, 43213, United States
Oklahoma Heart Institute
Tulsa, Oklahoma, 74104, United States
Kaiser Permanente Northwest
Clackamas, Oregon, 97015, United States
Providence Heart & Vascular Institute Portland
Portland, Oregon, 97225, United States
Legacy Emanuel Medical Center
Portland, Oregon, 97227, United States
Allegheny Singer Research Institute
Pittsburgh, Pennsylvania, 15212, United States
UPMC Presbyterian Shadyside
Pittsburgh, Pennsylvania, 15213, United States
Pinnacle Health Harrisburg
Wormleysburg, Pennsylvania, 17043, United States
Lankenau Medical Center
Wynnewood, Pennsylvania, 19096, United States
Baptist Memorial Hospital Memphis
Germantown, Tennessee, 38138, United States
Methodist Le Bonheur Healthcare
Germantown, Tennessee, 38138, United States
Parkwest Medical Center
Knoxville, Tennessee, 37923, United States
Saint Thomas Health
Nashville, Tennessee, 37205, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Ascension Texas Cardiovascular
Austin, Texas, 78705, United States
UT Southwestern Medical Center
Dallas, Texas, 75235, United States
HCA Houston Healthcare Medical Center
Houston, Texas, 77004, United States
The University of Texas Health Science Center
Houston, Texas, 77030, United States
The Heart Hospital Baylor Plano
Plano, Texas, 75093, United States
Methodist Hospital of San Antonio
San Antonio, Texas, 78229, United States
Kaiser Mid Atlantic
McLean, Virginia, 22102, United States
Sentara Norfolk General Hospital
Norfolk, Virginia, 23507, United States
Swedish Medical Center
Seattle, Washington, 98112, United States
The Prince Charles Hospital
Chermside, Queensland, 4032, Australia
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
Monash Health
Clayton, Victoria, 3168, Australia
St. Paul's Hospital
Vancouver, British Columbia, V6E1M7, Canada
Hamiton Health Services
Hamilton, Onterio, L8L 2X2, Canada
Kokura Memorial Hospital
Fukuoka, Kyushu, 802-8555, Japan
Sendai Kousei Hospital
Sendai, Miyagi, 981-0914, Japan
Sakakibara Heart Institute
Fuchū, Tokyo, 183-0003, Japan
Keio University Hospital
Shinjuku, Tokyo, 160-8582, Japan
AMC Amsterdam
Amsterdam, North Holland, 1105 AZ, Netherlands
Leiden Universitair Medisch Centrum
Leiden, South Holland, 2333, Netherlands
Erasmus Rotterdam
Rotterdam, South Holland, 3015, Netherlands
Hôpitaux Universitaire de Genève
Geneva, 1205, Switzerland
Universitätsspital Zürich
Zurich, 8091, Switzerland
Related Publications (1)
Genereux P, Makkar R, Bax JJ, Pibarot P, Lindman BR, Prince H, Park B, Cohen DJ, Mack MJ, Leon MB. Design and rationale of the prospective, randomized, controlled trial to assess the management of moderate aortic stenosis by clinical surveillance or transcatheter aortic valve replacement: The PROGRESS Trial. Am Heart J. 2026 Mar 25:107433. doi: 10.1016/j.ahj.2026.107433. Online ahead of print.
PMID: 41895563DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe Généreux, MD
Morristown Medical Center, Morristown, NJ, USA
- PRINCIPAL INVESTIGATOR
Jeroen J Bax, MD, PhD
Leiden University Medical Center, Leiden, The Netherlands
- PRINCIPAL INVESTIGATOR
Raj Makkar, MD
Cedars-Sinai Medical Center, Los Angeles, CA, USA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2021
First Posted
May 17, 2021
Study Start
October 12, 2021
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
June 1, 2037
Last Updated
December 17, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share